Biofortuna to Provide HLA Kits for Lab901's PCR-Based Diagnostic Platform
November 17, 2009
Biofortuna to Provide HLA Kits for Lab901's PCR-Based Diagnostic Platform
Lab901 will optimize its ScreenTape PCR diagnostics platform for use with Biofortuna’s multiplex PCR diagnostics kits for the detection of celiac disease and other HLA-related disease such as reactive arthritis, diabetes, and drug hypersensitivity.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Biofortuna, Abbott Extend Distribution Deal
April 25, 2012 / GenomeWeb Daily News - Abbott to Distribute Biofortuna's Freeze-Dried HLA Typing Kits
April 21, 2011 / PCR Insider - Abbott Obtains Rights to Distribute Biofortuna HLA-typing Kits
April 19, 2011 / GenomeWeb Daily News - Agilent Acquires Lab901 to Bolster Electrophoresis Play; Will Evaluate Potential Dx Apps
March 3, 2011 / PCR Insider - Agilent's Array Business Gains RNA QC Application through Lab901 Buy
March 1, 2011 / BioArray News